CROI 2018: ART Use With TB Therapy
Discussion - What do the latest clinical data show about giving rifampin with dolutegravir, bictegravir, or tenofovir alafenamide? (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - April 27, 2018 Category: Infectious Diseases Source Type: research
Intersection of the HIV and Opioid Epidemics: From Crisis to Evidence-Based Interventions
Slideset - In this downloadable slideset, Frederick L. Altice, MD, reviews the HIV treater ’s role at the intersection of HIV infection, HCV infection, and the opioid crisis. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - April 26, 2018 Category: Infectious Diseases Source Type: research
HIV Treatment Optimization: 2018
Slideset - In this downloadable slideset, Eric S. Daar, MD, provides a comprehensive update on ART management. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - April 26, 2018 Category: Infectious Diseases Source Type: research
HIV Alert: Options for Integrase Inhibitor Therapy Following Recent Drug Approvals
Audio - Listen to downloadable audio from a series of live Webinars by Paul E. Sax, MD, and Brian Wood, MD, in which the use of recently approved integrase inhibitor –based regimens is discussed and audience questions on this subject are addressed. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - April 23, 2018 Category: Infectious Diseases Source Type: research
Contemporary Management of HIV: New Data From CROI 2018
Slideset - In this downloadable slideset, Daniel R. Kuritzkes, MD, and Program Directors Joseph J. Eron, Jr., MD, and Princy N. Kumar, MD, review key HIV data presented at the CROI 2018 meeting. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - April 20, 2018 Category: Infectious Diseases Source Type: research
CROI 2018: Randomized Trial Data on the Risk of IRIS When Starting INSTI-Based ART
Discussion - Should patients with advanced HIV disease be started on INSTI-based regimens? (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - April 17, 2018 Category: Infectious Diseases Source Type: research
Key Studies Influencing My Practice Following CROI 2018
Audio - In this downloadable audio of a live Webinar, Chloe Orkin, MBChB, FRCP, MD, provides a rapid update on the clinical impact of new data reported at the Boston meeting. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - April 16, 2018 Category: Infectious Diseases Source Type: research
Expert Insights in Selecting a Switch Regimen for Virologically Suppressed HIV-Infected Patients
Slideset - In this slideset, Babafemi Taiwo, MBBS, discusses expert approaches to selecting an HIV switch regimen in a series of cases studies involving HIV-infected patients with virologic suppression on their current ART regimen. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 13, 2018 Category: Infectious Diseases Source Type: research
Expert Insights in Selecting a Switch Regimen for Virologically Suppressed HIV-Infected Patients
Interactive Virtual Presentation - In this CME-certified activity, Babafemi Taiwo, MBBS, presents a series of topical case studies featuring virologically suppressed patients with HIV infection who require a change in ART and discusses how our expert faculty chose to manage them. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 12, 2018 Category: Infectious Diseases Source Type: research
Substudy of Study 1717: Platelet Reactivity to Collagen Decreases After Switch From ABC/3TC-Containing to TAF/FTC-Containing ART
Conference Capsule - Following switch from ABC, patients had increases in collagen receptor glycoprotein VI expression and soluble receptor levels. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 12, 2018 Category: Infectious Diseases Source Type: research
DAWNING: Higher Efficacy Rates With DTG + WHO-Recommended Second-line NRTIs vs LPV/RTV-Based ART
Conference Capsule - Independent of the NRTI backbone, a higher rate of patients receiving second-line DTG-based ART achieved HIV-1 RNA (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 12, 2018 Category: Infectious Diseases Source Type: research
Phylogenetic Analysis Identifies Clusters of HIV-Infected Persons With High Transmission Rates
Conference Capsule - Prioritizing public health interventions for these transmission networks, particularly young Hispanic MSM, may reduce further incidences of infections (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 12, 2018 Category: Infectious Diseases Source Type: research
Baseline M184V Not Associated With Increased Probability of Virologic Failure in Virologically Suppressed Italian Patients Switching to Lamivudine-Based Dual Therapy
Conference Capsule - In this retrospective analysis, patients with M184V or hepatitis C virus coinfection had a significantly higher probability of viral blips. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 12, 2018 Category: Infectious Diseases Source Type: research
Bisphosphonate Use Results in Additional BMD Gains at Spine, but Not at Hip, in HIV-Infected Patients With Low BMD Switching From TDF- to TAF-Containing ART
Conference Capsule - Concomitant use of bisphosphonates and switch to TAF also associated with additional improvement in T-score at spine, but not at hip. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 10, 2018 Category: Infectious Diseases Source Type: research
DolPHIN-1 Interim Analysis: Dolutegravir-Based Regimen Appears Sufficient at Standard Dose for Women With HIV Starting ART in Third Trimester
Conference Capsule - HIV-1 RNA (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 10, 2018 Category: Infectious Diseases Source Type: research
